Greg Harrison
Stock Analyst at Scotiabank
(0)
# 4532
Out of 5,240 analysts
65
Total ratings
33.33%
Success rate
-15.00%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Vertex Pharmaceutica... | Maintains: Sector Perform | 426 430 | 411 | 4.62% | 3 | Dec 23, 2024 | |
Keros Therapeutics | Maintains: Sector Outperform | 77 44 | 12.52 | 251.44% | 4 | Dec 13, 2024 | |
Agios Pharmaceutical... | Maintains: Sector Outperform | 53 75 | 33.33 | 125.02% | 4 | Dec 9, 2024 | |
BridgeBio Pharma | Maintains: Sector Outperform | 45 48 | 35.51 | 35.17% | 3 | Nov 25, 2024 | |
Apellis Pharmaceutic... | Maintains: Sector Perform | 35 30 | 27.69 | 8.34% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 62 70 | 57.91 | 20.88% | 2 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 23 27 | 17.05 | 58.36% | 7 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 305 310 | 240.92 | 28.67% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 60 | 34.59 | 73.46% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 18 | 7.22 | 149.31% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Perform | 24 | 23.21 | 3.4% | 3 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 30 | 11.37 | 163.85% | 4 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 6 | 2.94 | 104.08% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 50 | 10.45 | 378.47% | 3 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 22 | 7.88 | 179.19% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 1.14 | 1215.79% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 303 280 | 364.56 | -23.2% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 89 91 | 9.68 | 840.08% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.65 | 38.73% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 2 | 1.02 | 47.06% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 9.1 | 328.57% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | 8.59 | -65.08% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 3.81 | 1737.27% | 1 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 20 | n/a | n/a | 2 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 8 | 11.38 | -29.7% | 1 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 25 7 | n/a | n/a | 4 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 54 | 21.7 | 148.85% | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 6 | 0.9 | 566.67% | 2 | Mar 14, 2022 |